GLP-1 receptor agonists improve glycemic and weight outcomes in children with type 2 diabetes, finds study

In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes, according to a study published in JAMA Pediatrics.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup